Fundamental Analysis
39 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +2.8% | -9.4% | 2 / 3 | -0.5% | +0.45 pp | +0.11 pp | +13.2% | 1.07 | 5.03 | 303 | −0,5% | 10,3 | +2,8% | 5.03 | 10.46 | −51,9% |
| Pts | 0 | 0 | 8 | 0 | 8 | 8 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 11.400 (close price on 2026-10-19)EPS (TTM): 2.268
Financial charts
1.Revenue & growth
VND bn303Q2/26
1.Revenue & growth
VND bn303Q2/26
2.Profit & growth
VND bn10,3Q2/26
3.Profit mix (Penman)
VND bn32,1Q2/26
4.Margins & cost structure
%15.3%Q2/26
5.Returns & cash cycle
% · days9.8%Q2/26
6.Earnings quality & cash
VND bn-22,0Q2/26
7.Asset structure
VND bn531Q2/26
8.Funding & debt health
VND bn · times531Q2/26
9.Revenue backlog
VND bn7,03Q2/26
10.Valuation
times · %5,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %920Q2/26
Adjusted EPS growth, latest quarter
2.8%
Average adjusted EPS growth, 3 quarters
-9.4%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26